Register
Login:
Share:
Email Facebook Twitter




GWP Share Chat - RSS Feed

Gw Pharmaceuticals Share Chat (GWP)



Share Price: 438.00Bid: 438.00Ask: 439.50Change: 0.00 (0.00%)No Movement on Gw Pharm.
Spread: 1.50Spread as %: 0.34%Open: 438.00High: 440.25Low: 425.75Yesterday’s Close: 438.00


Share Discussion for Gw Pharm. (GWP)


Thread ViewThread View
Please Login or Register to post messages
Posts per page:


Premium Membership
wuntbedruv
Posts: 14
Off Topic
Opinion:No Opinion
Price:229.00
pricing
27 Jan '14
So- with all the volumes purchased, why is the price decreasing. This is a regular feature with this stock. Why?
 
Suzz
Posts: 5,124
Off Topic
Opinion:No Opinion
Price:242.00
Presidential endorsement
20 Jan '14
Crumbles
Posts: 58
Off Topic
Opinion:Hold
Price:241.75
i.e.
20 Jan '14
£3.79, so no surrender remains the best course for now
Crumbles
Posts: 58
Off Topic
Opinion:Hold
Price:241.75
Price conversion
20 Jan '14
If you bookmark the $ to £ converter you can always ensure you're up to date.today it is running at 0.61. Thus 73/12*0.61 = approx UKprice at today's exchange rate.for $73 target.
bifter
Posts: 27
Off Topic
Opinion:No Opinion
Price:242.50
View Thread (3)
RE: target price $73--16.01.14
20 Jan '14
In an attempt to answer my own question would the following be right?

73/12 then convert from $ to GBP. Comes out to +/- 369 GBp for me.

Seems to work for current prices too.
bifter
Posts: 27
Off Topic
Opinion:No Opinion
Price:242.00
View Thread (3)
RE: target price $73--16.01.14
20 Jan '14
If GWPH where to = $73 what approximate value will GWP have in GBp? What's the ratio between the two?

Would I be right in thinking one can roughly predict the next days opening changes based on NASDAQ performance the previous day whilst UK market is asleep?

Sorry if these are dumb questions I'm a very amateur trader so probably don't know many of the basics that I should know... Thanks to anyone who can help me!
Crumbles
Posts: 58
Off Topic
Opinion:Hold
Price:232.50
Alert: scammers at it again
17 Jan '14
My wife took a call tonight from someone offering to buy our GWP shares for between £6 and £16 a share. Usual guff about mystery buyer trying to accumulate enough for a takeover. En garde, mes amis. See my earlier posts re this particular boiler house scam for further details. If approached, ask the caller what proportion of GWP shares are held by management and institutions such as Prudential and M&G combined. The scammers' scenario is quickly revealed as sheer b*ll*cks. The dog's b*ll*cks are the market forces driving this share onwards. Watch and wait; the best is yet to come. No surrender!
bluerose
Posts: 2,413
Off Topic
Opinion:No Opinion
Price:245.75
View Thread (3)
target price $73--16.01.14
16 Jan '14
One of the advantages of having wide Wall Street coverage is the ability to constantly screen even the smallest tidbits of research that is put out each day. Many times firms will put out long-winded, excruciating detail that includes massive graphs and page after page of balance sheet data. Sometimes the data looks small in quantity but is actually huge in quality.

The analysts at Piper Jaffray have returned from meeting with some of the top biotechs the cover, and they have gleaned some interesting morsels that could be huge as the year wears on

Read more: Piper Jaffray Has Four Biotech Stocks to Buy With Huge Potential - 24/7 Wall St. http://247wallst.com/healthcare-business/2014/01/16/piper-jaffray-has-four-biotech-stocks-to-buy-with-huge-potential/#ixzz2qZJw4K8d
Follow us: @247wallst on Twitter | 247wallst on Facebook
bluerose
Posts: 2,413
Off Topic
Opinion:No Opinion
Price:245.75
target price $73
16 Jan '14
GW Pharmaceuticals PLC (NASDAQ: GWPH) recently entered an agreement with Ipsen, a French pharmaceutical company to promote and distribute Sativex, its controversial cannabis spray, in Latin America (excluding Mexico and the Caribbean islands). Sativex is used to treat spasticity in multiple sclerosis patients, and has been approved in 24 countries, primarily across Europe. The company also announced the pending use patent on Epidolex could extend exclusivity of the potential migraine drug until 2032. This is another cannabis related extract. The Piper Jaffray price target for the stock is $73. The Thomson/First Call target is set at $54.50. The stock closed Wednesday at $51.

Read more: Piper Jaffray Has Four Biotech Stocks to Buy With Huge Potential - 24/7 Wall St. http://247wallst.com/healthcare-business/2014/01/16/piper-jaffray-has-four-biotech-stocks-to-buy-with-huge-potential/#ixzz2qZJTzRPr
Follow us: @247wallst on Twitter | 247wallst on Facebook





Sign up for Live Prices


Home  |  Contact Us  |  About Us  |  Careers  |  Advertise with Us  |  Sitemap  |  Terms & Conditions  |  Cookies  |  Privacy


Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.